NeuroSigma ADHD Trial of Monarch eTNS System Completes Enrollment
NeuroSigma, Inc. announced the completion of enrollment for the ATTENS trial, a multicenter, double-blind, placebo-controlled study evaluating the effectiveness...
Rakovina & Variational AI Achieve Cancer Drug Milestone
Rakovina Therapeutics has achieved a significant milestone by developing a shortlist of AI-generated molecules targeting ATR, designed for central...
ORIC-944 Phase 1b Data, 2024 Highlights, Milestones
ORIC Pharmaceuticals announced encouraging early safety and efficacy data from a Phase 1b trial of ORIC-944 combined with apalutamide...
Ashvattha Therapeutics Secures $50M, Unveils Promising Ophthalmology Trial Results
Ashvattha Therapeutics secured up to $50 million in extended Series B funding, led by Tribe Capital with continued support...
Brio-II Phase 3 Study Shows Positive Topline Data for Brimochol™ PF in Presbyopia Treatment
Tenpoint Therapeutics announced positive topline results from its Phase 3 BRIO-II trial of BRIMOCHOL™ PF, a carbachol/brimonidine tartrate eye...
Rapport Therapeutics Announces Promising Phase 1 Data for CNS Disorders
Rapport Therapeutics (Nasdaq: RAPP) announced positive Phase 1 results for RAP-219, a drug candidate for central nervous system disorders....
MRNA Cancer Vaccine Clinical Trials & Research
Over 60 mRNA cancer vaccine candidates are currently in clinical trials, with two reaching Phase III. BioNTech‘s BNT111, a...
Alkeus GLY2 prevents Stargardt Progression in Phase 3 Study
Alkeus Pharmaceuticals announced positive interim data from its TEASE-3 Stargardt disease study. Two additional participants who completed 24 months...
IO Biotech’s Cancer Vaccine Trial Enrolls Patients with Melanoma and Head/Neck Cancer
IO Biotech has completed enrollment in its Phase 2 basket trial, IOB-032/PN-E40, ahead of schedule. The trial evaluates the...
Acumen Pharmaceutics Alzheimer’s Prevention Study in Journal
Acumen Pharmaceuticals announced positive Phase 1 clinical trial results for sabirnetug (ACU193), a potential Alzheimer’s diseaseAlzheimer’s disease treatment targeting...